EVRYSDI
Risdiplam
- Strength
- 5 mg/1
- Form
- Tablet
- Class
- Survival of Motor Neuron 2 Splicing Mod…
Genentech, Inc.
Not stocked by us — reference only
Risdiplam
Listed by Genentech, Inc.
| Dosage form | Powder, For Solution |
|---|---|
| Route | Oral |
| Drug class | Survival of Motor Neuron 2 Splicing Modifier |
| Approval route | NDA — original brand approval |
| NDC code | 50242-175 |
| FDA application | NDA213535 |
| RxNorm concept | 2390940 |
| Package sizes listed | 1 |
| Marketed since | August 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Risdiplam
Genentech, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.